Comparison of adverse effects following immunization with vaccine containing whole-cell vs. acellular pertussis...

Area of Science:

• Pediatrics
• Immunology
• Public Health

Background:

• Pertussis vaccines are crucial for preventing whooping cough.
• Two main types exist: whole-cell (wP) and acellular (aP) pertussis vaccines.
• Understanding their comparative safety profiles is vital for public health policy.

Purpose of the Study:

• To compare the incidence of adverse effects following whole-cell and acellular pertussis vaccinations.
• To analyze specific adverse events, including severe reactions and allergic responses.

Main Methods:

• Retrospective analysis of mandatory routine surveillance data for Adverse Events Following Immunization (AEFI).
• Data collected in Poland between 2001 and 2005.
• Focus on children under two years of age.

Main Results:

• Children vaccinated with whole-cell pertussis vaccines experienced approximately twice the incidence of adverse effects compared to those receiving acellular vaccines.
• A significantly higher relative risk (RR = 4.75) of high-pitched cry was observed with whole-cell vaccines.
• No significant differences were found in the incidence of severe reactions like encephalopathy and nonfebrile seizures, nor in allergic reactions.

Conclusions:

• Whole-cell pertussis vaccines are associated with a higher overall incidence of adverse effects in young children compared to acellular vaccines.
• While common adverse events are more frequent with wP vaccines, severe neurological and allergic reactions do not show a significant difference between the two vaccine types.
• These findings support the use of acellular pertussis vaccines due to a more favorable safety profile regarding common adverse events.